Jiang Y, Liu Y, Huang H, Zhao T, Zhao Z, Gao Y
Cancer Immunol Immunother. 2025; 74(3):78.
PMID: 39891700
PMC: 11787098.
DOI: 10.1007/s00262-024-03926-9.
Teng J, Jia Z, Gao F, Guan Y, Yao L, Ma C
Cell Biol Toxicol. 2024; 41(1):18.
PMID: 39729199
PMC: 11680619.
DOI: 10.1007/s10565-024-09967-1.
Huang C, Hsieh M, Wu Y, Huang P, Lin Y, Tsao K
Int J Mol Sci. 2024; 25(20).
PMID: 39456722
PMC: 11507259.
DOI: 10.3390/ijms252010941.
Ogbodo J, Egba S, Ogbodo C, Onwurah I, Njoku O
Heliyon. 2024; 10(17):e37015.
PMID: 39286128
PMC: 11402925.
DOI: 10.1016/j.heliyon.2024.e37015.
Cartes-Velasquez R, Vera A, Antilef B, Sanhueza S, Lamperti L, Gonzalez-Ortiz M
Biomolecules. 2024; 14(7).
PMID: 39062560
PMC: 11274706.
DOI: 10.3390/biom14070846.
Dynamic Changes in the Immune Microenvironment in Tumor-Draining Lymph Nodes of a Lewis Lung Cancer Mouse Model After Microwave Ablation.
Sang J, Liu P, Wang M, Xu F, Ma J, Wei Z
J Inflamm Res. 2024; 17:4175-4186.
PMID: 38979433
PMC: 11228081.
DOI: 10.2147/JIR.S462650.
Failed Induction of the T1 System in T2 Dominant Patients: The Cancer-Permissive Immune Macroenvironment.
Yanuck S
Integr Med (Encinitas). 2024; 23(2):24-35.
PMID: 38911450
PMC: 11193407.
SARS-CoV-2 inflammation durably imprints memory CD4 T cells.
Gray-Gaillard S, Solis S, Chen H, Monteiro C, Ciabattoni G, Samanovic M
Sci Immunol. 2024; 9(96):eadj8526.
PMID: 38905326
PMC: 11824880.
DOI: 10.1126/sciimmunol.adj8526.
Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies.
Ghimire P, Kinnersley B, Karami G, Arumugam P, Houlston R, Ashkan K
Neurooncol Adv. 2024; 6(1):vdae055.
PMID: 38680991
PMC: 11046988.
DOI: 10.1093/noajnl/vdae055.
Interactions Between HDL and CD4+ T Cells: A Novel Understanding of HDL Anti-Inflammatory Properties.
Atehortua L, Davidson W, Chougnet C
Arterioscler Thromb Vasc Biol. 2024; 44(6):1191-1201.
PMID: 38660807
PMC: 11111342.
DOI: 10.1161/ATVBAHA.124.320851.
Dynamic immune signatures of patients with advanced non-small-cell lung cancer for infection prediction after immunotherapy.
Luo Y, Shen C, Chiang C, Huang H, Chen Y
Front Immunol. 2024; 15:1269253.
PMID: 38343550
PMC: 10853389.
DOI: 10.3389/fimmu.2024.1269253.
The RNA mA writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications.
Su W, Che L, Liao W, Huang H
Front Immunol. 2024; 15:1335774.
PMID: 38322265
PMC: 10845340.
DOI: 10.3389/fimmu.2024.1335774.
Beyond schistosomiasis: unraveling co-infections and altered immunity.
Perera D, Koger-Pease C, Paulini K, Daoudi M, Ndao M
Clin Microbiol Rev. 2024; 37(1):e0009823.
PMID: 38319102
PMC: 10938899.
DOI: 10.1128/cmr.00098-23.
Enhanced detection of antigen-specific T cells by a multiplexed AIM assay.
Lemieux A, Sannier G, Nicolas A, Nayrac M, Delgado G, Cloutier R
Cell Rep Methods. 2024; 4(1):100690.
PMID: 38228152
PMC: 10831934.
DOI: 10.1016/j.crmeth.2023.100690.
A History and Atlas of the Human CD4 T Helper Cell.
Crater J, Dunn D, Nixon D, Furler OBrien R
Biomedicines. 2023; 11(10).
PMID: 37892982
PMC: 10604283.
DOI: 10.3390/biomedicines11102608.
Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review.
Wu X, Zhou Z, Cao Q, Chen Y, Gong J, Zhang Q
Front Immunol. 2023; 14:1268188.
PMID: 37753092
PMC: 10518452.
DOI: 10.3389/fimmu.2023.1268188.
CD4+ T-cell subsets in autoimmune hepatitis: A review.
Chen H, Han Z, Fan Y, Chen L, Peng F, Cheng X
Hepatol Commun. 2023; 7(10).
PMID: 37695088
PMC: 10497257.
DOI: 10.1097/HC9.0000000000000269.
Significance of Th17 and Treg in Treatment Efficacy and Outcome in Pediatric Acute Lymphoblastic Leukemia.
Kretowska-Grunwald A, Sawicka-Zukowska M, Kowalska M, Basaj A, Krawczuk-Rybak M, Moniuszko M
Int J Mol Sci. 2023; 24(15).
PMID: 37569699
PMC: 10418382.
DOI: 10.3390/ijms241512323.
Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer.
Xie X, Liang H, Jiangting W, Wang Y, Ma X, Tan Z
Front Mol Biosci. 2023; 10:1198557.
PMID: 37484531
PMC: 10360201.
DOI: 10.3389/fmolb.2023.1198557.
Immune cells and their related genes provide a new perspective on the common pathogenesis of ankylosing spondylitis and inflammatory bowel diseases.
Ding Y, Yang Y, Xue L
Front Immunol. 2023; 14:1137523.
PMID: 37063924
PMC: 10101339.
DOI: 10.3389/fimmu.2023.1137523.